Showing results (191-200 of 221) with videos related to

Sort By:
Pageof 23
Nature Reviews. Disease Primers|November 6, 2020
Paediatric functional abdominal pain disordersNikhil Thapar, Marc A Benninga, Michael D Crowell, et al.
Gastrointestinal Endoscopy|March 12, 2013
Impact of fentanyl in lieu of meperidine on endoscopy unit efficiency: a prospective comparative study in patients undergoing EGDIvana Dzeletovic, M Edwyn Harrison, Michael D Crowell, et al.
Gastrointestinal Endoscopy|November 18, 2018
Intestinal metaplasia of the gastric cardia: findings in patients with versus without Barrett's esophagusHassan A Siddiki, Dora M Lam-Himlin, Allon Kahn, et al.
Dysphagia|June 5, 2014
Esophageal peristaltic defects in adults with functional dysphagiaShiva K Ratuapli, Stephanie L Hansel, Sarah B Umar, et al.
Clinical and Translational Gastroenterology|June 30, 2017
Impaired Esophageal Motility and Clearance Post-Lung Transplant: Risk For Chronic Allograft FailureAnupong Tangaroonsanti, Augustine S Lee, Michael D Crowell, et al.
Gastroenterology|June 10, 2004
Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndromeMatthew D Coates, Christine R Mahoney, David R Linden, et al.
Clinical Transplantation|March 18, 2014
Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantationRebecca L Corey, Michael D Whitaker, Michael D Crowell, et al.
The American Journal of Gastroenterology|February 16, 2012
Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowthShiva K Ratuapli, Taylor G Ellington, Mary-Teresa O'Neill, et al.
The American Journal of Gastroenterology|June 20, 2020
Postobesity Surgery Esophageal Dysfunction: A Combined Cross-Sectional Prevalence Study and Retrospective AnalysisAlexander T Miller, Reem Matar, Barham K Abu Dayyeh, et al.
Neurogastroenterology and Motility|September 5, 2013
Novel partial 5HT3 agonist pumosetrag reduces acid reflux events in uninvestigated GERD patients after a standard refluxogenic meal: a randomized, double-blind, placebo-controlled pharmacodynamic studyR S Choung, G R Locke, D D Francis, et al.
Pageof 23